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The hemolytic lectin CEL-III forms transmembrane pores in the 2 
membranes of target cells. A study on the effect of site-directed mutation at 3 
Lys405 in domain 3 of CEL-III indicated that replacements of this residue by 4 
relatively smaller residues lead to a marked increase in hemolytic activity, 5 
suggesting that moderately destabilizing domain 3 facilitates formation of 6 
transmembrane pores through conformational changes.  7 
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Keywords: hemolysin; sea cucumber; lectin; pore-forming protein; 9 
site-directed mutagenesis  10 
 11 
CEL-III is a hemolytic lectin isolated from the sea cucumber Cucumaria 12 
echinata. This lectin binds galactose-containing carbohydrates on the surface of 13 
cell membranes in a Ca2+-dependent manner.1) CEL-III contains two 14 
carbohydrate-binding domains (domains 1 and 2), which adopt a ricin-type 15 
(R-type) lectin fold,2) also known as β-trefoil fold,3, 4) although they require 16 
Ca2+ ions for binding to specific carbohydrates. Domains 1 and 2 are composed 17 
of three subdomains, each of which contains a carbohydrate-binding sites, 18 
except for subdomain 1β. Specific carbohydrates are recognized through 19 
coordinate bonds with Ca2+ and via hydrogen bond networks around the 20 
residues lining these binding sites.4) On the other hand, one third of the 21 
C-terminal region of CEL-III corresponds to domain 3. Domain 3 contains a 22 
hydrophobic region, and is involved in the formation of transmembrane pores in 23 
targeted cell membranes. After binding to target cells via five 24 
carbohydrate-binding sites in domains 1 and 2, and inserting into the membrane 25 
through hydrophobic regions, CEL-III generates transmembrane pores by 26 
associating with itself, forming heptamers (Fig. 1).5) These pores can lead to 27 
Fig. 1 
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hemolysis or cell death by disrupting the balance of ions across the cell 1 
membrane.6) Our previous site-directed mutagenesis study, in which various 2 
residues throughout domain 3 were mutated to alanine residues,7) identified 3 
some residues closely associated with the hemolytic action of CEL-III. Among 4 
them, Lys405 was one of the most conspicuous because its mutation to alanine 5 
led to a drastic increase in hemolytic activity. The mutant protein (K405A) 6 
showed a 360-fold increase in hemolytic activity, compared to wild-type (WT) 7 
protein. In order to elucidate the function of this residue in the hemolytic action 8 
of CEL-III, we have conducted a study further mutating this and related 9 
residues.  10 
Mutations were introduced into the gene encoding CEL-III with a 11 
QuikChange site-directed mutagenesis kit (Agilent, Santa Clara, CA), using 12 
primers (33 nucleotides) and the CEL-III cDNA (DDBJ database accession 13 
number AB109017) as a template.8) Plasmids containing the mutated genes 14 
were used to transform Escherichia coli BL21-codonplus (DE3)-RIPL cells 15 
(Novagen). Cells were cultured at 37°C in lysogeny broth media, on a shaking 16 
platform. Once the cell culture reached mid-log phase (optical density readings 17 
of 0.6–0.7, at 600 nm), protein expression was induced by the addition of 18 
isopropyl-β-D-thiogalactopyranoside to a final concentration of 0.4 mM. Cells 19 
were incubated for an additional 5 h at 37°C. The recombinant protein mutants 20 
were isolated in inclusion bodies following disruption of the cells by sonication. 21 
The inclusion bodies were solubilized in ‘solubilization buffer’ (0.2 M NaCl, 1 22 
mM ethylenediamine tetraacetic acid, 6 M guanidine hydrochloride, 50 mM 23 
Tris-HCl, pH 8.0), and the protein was refolded in ‘refolding buffer’ (0.4 M 24 
L-arginine, 2 mM EDTA, 5 mM reduced glutathione, 0.5 mM oxidized 25 
glutathione, 0.1 M Tris-HCl, pH 8.0.9) After dialysis against Tris-buffered saline 26 
(TBS; 0.15 M NaCl, 10 mM Tris-HCl, pH 7.5) containing 10 mM CaCl2, the 27 
protein was purified by affinity chromatography on a lactose-Cellufine column 28 
 4 
(1 × 3 cm).6) The hemolytic activities of the CEL-III mutants were determined 1 
by monitoring the absorbance of a suspension of erythrocytes at 540 nm (which 2 
measures the release of hemoglobin) after mixing with the CEL-III mutants in 3 
10 mM Tris-HCl (pH 8.5) containing 0.15 M NaCl and 10 mM CaCl2 at 20°C 4 
for 1 h, as previously described.6)  5 
Since the mutant K405A showed a remarkable increase in hemolytic 6 
activity in our previous study,7) several mutant proteins were prepared with 7 
different amino acid residues, (Ala, Ser, Glu, Arg, and Leu) at position 405 8 
(K405A, K405S, K405E, K405R, and K405L, respectively), and their activity 9 
was examined. Among them, we were unable to refold K405L into a soluble 10 
form because of its strong tendency to auto-aggregate. This suggests that a 11 
leucine residue introduced at position 405 may have brought about an excessive 12 
change in the local environment inside domain 3, due to its hydrophobic 13 
side-chain, leading to the formation of the aggregates. On the other hand, the 14 
other CEL-III mutants were successfully refolded to soluble form. The refolded 15 
mutants were purified by affinity chromatography using a lactose-Cellufine 16 
column, which by itself indicates that they possessed intact 17 
carbohydrate-binding activity. Following elution from the affinity column using 18 
lactose, the CEL-III mutants were dialyzed against TBS to remove bound 19 
lactose, and used in a hemolytic assay. 20 
Figure 2A compares the hemolytic activity of the various CEL-III mutants. 21 
Their hemolytic activity was determined from the absorbance at 540 nm, due to 22 
hemoglobin release from rabbit erythrocytes, after 1 h incubation with the 23 
proteins. In accordance with our previous results,7) K405A-CEL-III exhibited a 24 
much higher activity compared to WT-CEL-III. Concentrations for 50% 25 
hemolysis (HC50) were 5.7 µg/ml for WT-CEL-III and 0.26 µg/ml for 26 
K405A-CEL-III, confirming enhanced activity by the K405A mutant. In 27 
addition to K405A, a remarkable increase in activity was also observed for 28 
Fig. 2 
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K405S (HC50 = 0.36 µg/ml), whereas the other mutants, K405E and K405R, 1 
showed much lower activities (HC50 = 51 µg/ml and 29 µg/ml, respectively). As 2 
seen in Fig. 3A, Lys405 is situated in the interior of domain 3 in the CEL-III 3 
monomer, forming an ionic bond with Asp371, contributing to the stabilization 4 
of the domain structure. Therefore, the mutation of Lys405 to residues with 5 
small, uncharged side-chains (K405A and K405S) may have partially 6 
destabilized the structure of domain 3 by disrupting this ionic bond. Since the 7 
hemolytic action of CEL-III proceeds via large conformational changes of 8 
domain 3 to form heptamers, such a ‘loosening’ partial disruption might 9 
conceivably facilitate heptamerization (and therefore promote pore formation) 10 
in target cell membranes. However, it is noteworthy that the ionic bond between 11 
Lys405 and Asp371 is still preserved in the heptameric form of native 12 
CEL-III,5) suggesting that the enhancement of activity is brought about by 13 
destabilization of the local structure of the monomeric form, rather than by a 14 
loss of a particular bond between amino acid residues. This seems to be related 15 
to our previous observation that the hemolytic activity of CEL-III is also 16 
enhanced by mutation of three valine residues (Val341, Val343, and Val345) to 17 
alanine residues, which presumably lowers the stability of domain 3.10) In 18 
contrast to K405A and K405S, decreased activity resulted in the case of 19 
mutations of K405 to relatively larger residues with charged side-chains 20 
(K405E and K405R). We speculate that the side-chains of glutamate and 21 
arginine may have caused excessive destabilization of domain 3, by introducing 22 
either an oppositely charged side-chain (K405E) or a larger side-chain (K405R). 23 
Moderate destabilization in domain 3 arising from K405A and K405S 24 
mutations appears likely to be the basis for the enhanced hemolytic action.  25 
We also examined the effect of substitutions of Asp371, the counterpart 26 
residue in the ionic bond with Lys405. As shown in Fig. 2B, all the Asp371 27 
Fig. 3 
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mutants exhibited reduced activities, including the alanine mutation (D371A), 1 
in contrast to the case for Lys405 mutants. D371A and D371R CEL-III mutants 2 
only achieved a maximum of 20% hemolysis, and D371K had almost no 3 
activity. As shown in the close-up view around the contact region between 4 
subunits in heptameric CEL-III (Fig. 3B), the Asp371 side-chain forms a 5 
hydrogen bond with the Gln300 side-chain in the adjacent subunit, in addition 6 
to an ionic bond with Lys405. This suggests that the mutations of Asp371 led 7 
not only to the disruption of the ionic bond with Lys405, but also to interactions 8 
with a neighboring subunit required for heptamerization. As seen in Figure 3B, 9 
there are three other residues (Asn369, Asp373, and Arg378) involved in 10 
interactions between adjacent subunits in that vicinity. This region is assumed 11 
to be particularly important during the early stage of heptamerization; it forms a 12 
prepore ring on the cell membrane, which then triggers extension of the 13 
14-stranded β-barrel.5) The importance of these residues during the 14 
heptamerization process, owing to their formation of hydrogen bonds and ionic 15 
bonds, has also been suggested by the complete loss of activity in the R378A 16 
mutant7)—although Arg378 is fully exposed to aqueous solution in the original 17 
monomeric form (Fig. 3A). Taking these facts in to account, it seems reasonable 18 
to infer that the mutation of Asp371, which is expected to weaken the 19 
interaction between neighboring subunits, may significantly reduce the 20 
heptamerization efficiency needed for hemolytic action. 21 
In contrast to the current results, a slightly higher activity of the D371A 22 
mutant compared with that of the WT was observed in our previous 23 
experiment.7) Although the exact reason for this discrepancy is uncertain, it 24 
might be due to subtle differences in the folded states of the recombinant 25 
proteins that were prepared, including the WT protein. Besides R378A, K338A 26 
is another conspicuous mutant, showing an almost complete loss of hemolytic 27 
activity.7) As shown in Fig. 3A, Lys338 is exposed to aqueous solution on the 28 
 7 
surface of the protein in monomeric form, but it becomes relocated in the 1 
heptameric form to the end of the 14-stranded β-barrel, which is expected to be 2 
on the opposite side of the cell membrane. This suggests that this residue might 3 
play a particular role in β-barrel extension through interactions with the cell 4 
membrane. Investigation of the roles played by these specific residues would 5 
lead to further understanding of the mechanism of action of CEL-III, as well as 6 
other pore-forming proteins, which are widely distributed in different 7 
organisms. 8 
 9 
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Figure Legends 1 
Figure 1. Mechanism of hemolysis by CEL-III. 2 
(A) CEL-III binds to Gal/GalNAc-containing carbohydrate chains present on 3 
target cell membranes via its five carbohydrate-binding sites. (B) Triggered by 4 
the binding to the carbohydrate chains, domain 3 of CEL-III releases from 5 
domains 1 and 2. (C) CEL-III heptamerizes to form a transmembrane pore 6 
composed of domain 3. Only two of the seven pore molecules are shown here in 7 
side view, for convenient viewing. 8 
 9 
Figure 2. Hemolytic activity of the CEL-III mutants. 10 
The hemolytic activity of mutants with different amino acid substitutions at (A) 11 
position 405 or (B) at position 371 was compared with that of WT-CEL-III. The 12 
assay was performed by incubating the proteins separately for 1 h at 20°C with 13 
rabbit erythrocytes in 10 mM Tris-HCl, pH 8.5, containing 10 mM CaCl2. After 14 
centrifugation, the activities were determined by monitoring hemoglobin 15 
release from the erythrocytes at an absorbance wavelength of 540 nm. The 16 
highest hemolysis values obtained were used to define 100% activity. 17 
 18 
Figure 3. Three-dimensional structures of a CEL-III monomer (PDB ID: 19 
2Z48)4) and heptamer (PDB ID: 3W9T).5) 20 
The regions around Lys405 of (A) monomeric and, (B) heptameric forms of 21 
CEL-III are depicted in close-up view. Ca2+ (magenta) and Mg2+ (yellow) are 22 
shown as spheres. Hydrogen bonds and ionic bonds are depicted as dashed lines. 23 
Bound carbohydrate molecules are omitted. These models were prepared using 24 
the program PyMOL.11) 25 
 26 
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